Sunday, June 14, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 299 of 1,261
  1. US 11180468

    Prodrugs of urolithins and uses thereof

    Amazentis SA · Granted Nov 23, 2021 · Expires Nov 18, 2041

    granted
  2. US 11180466

    2-benzoylaminobenzamide derivatives as Bcl-3 inhibitors

    University College Cardiff Consultants Limited · Granted Nov 23, 2021 · Expires Nov 18, 2041

    granted
  3. US 11180444

    Polyimino ketoaldehydes

    NOVUM SPERO LTD · Granted Nov 23, 2021 · Expires Nov 18, 2041

    granted
  4. US 11180452

    Methods and compositions for selectively inhibiting pathogenic microbes

    The Board of Regents of the University of Oklahoma · Granted Nov 23, 2021 · Expires Nov 18, 2041

    granted
  5. US 11179494

    Collagenous tissue repair device

    Northwestern University · Granted Nov 23, 2021 · Expires Nov 18, 2041

    granted
  6. US 11179467

    Exenatide modifier and use thereof

    BrightGene Bio-Medical Technology Co., Ltd. · Granted Nov 23, 2021 · Expires Nov 18, 2041

    granted
  7. US 11179419

    Restimulation of cryopreserved tumor infiltrating lymphocytes

    Iovance Biotherapeutics, Inc. · Granted Nov 23, 2021 · Expires Nov 18, 2041

    granted
  8. US 11179400

    Heterocyclic compounds as RSV inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Nov 23, 2021 · Expires Nov 18, 2041

    granted
  9. US 11179439

    Methods and compositions for preventing and treating damage to the heart

    The Regents of the University of California · Granted Nov 23, 2021 · Expires Nov 18, 2041

    granted
  10. US 11179435

    Hangover alleviating composition containing conjugate of sesamol and peptide as active ingredient

    CAREGEN CO., LTD. · Granted Nov 23, 2021 · Expires Nov 18, 2041

    granted
  11. US 11179384

    Treatment of nonalcoholic fatty liver disease

    TAKEDA GMBH · Granted Nov 23, 2021 · Expires Nov 18, 2041

    granted
  12. US 11179376

    Salts of pyrazolo[1,5-a]pyridine derivative and use thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Nov 23, 2021 · Expires Nov 18, 2041

    granted
  13. US 11179352

    Dosage forms and methods for enantiomerically enriched or pure bupropion

    AXSOME THERAPEUTICS, INC. · Granted Nov 23, 2021 · Expires Nov 18, 2041

    granted
  14. US 11179351

    Dosage forms and methods for enantiomerically enriched or pure bupropion

    AXSOME THERAPEUTICS, INC. · Granted Nov 23, 2021 · Expires Nov 18, 2041

    granted
  15. US 11179336

    Manufacturing of bupivacaine multivesicular liposomes

    Pacira Pharmaceuticals, Inc. · Granted Nov 23, 2021 · Expires Nov 18, 2041

    granted
  16. US 11179367

    Pharmaceutical compositions for treating cystic fibrosis

    Vertex Pharmaceuticals Incorporated · Granted Nov 23, 2021 · Expires Nov 18, 2041

    granted
  17. US 11179327

    Compositions and methods for the treatment of presbyopia

    Lenz Therapeutics, Inc. · Granted Nov 23, 2021 · Expires Nov 18, 2041

    granted
  18. US 11178860

    Humanized C5 animals

    REGENERON PHARMACEUTICALS, INC. · Granted Nov 23, 2021 · Expires Nov 18, 2041

    granted
  19. US 11179477

    Method of using adeno-associated virus with variant capsid

    4D MOLECULAR THERAPEUTICS INC. · Granted Nov 23, 2021 · Expires Nov 18, 2041

    granted
  20. US 11180517

    Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use

    Compass Pathfinder Limited · Granted Nov 23, 2021 · Expires Nov 18, 2041

    granted
  21. US 11181520

    Systems and methods for high-resolution imaging

    The Board of Regents of the University of Texas System · Granted Nov 23, 2021 · Expires Nov 18, 2041

    granted
  22. US 11179394

    Method for treating cancer using a combination of Chk1 and ATR inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Nov 23, 2021 · Expires Nov 18, 2041

    granted
  23. US 11180483

    Substituted reverse pyrimidine Bmi-1 inhibitors

    PTC THERAPEUTICS, INC. · Granted Nov 23, 2021 · Expires Nov 18, 2041

    granted
  24. US 11179320

    Self-regulating osmotic gastroretentive drug delivery systems

    Amneal Complex Products Research LLC · Granted Nov 23, 2021 · Expires Nov 18, 2041

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.